Related Experiment Video
Updated: Aug 9, 2026
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors
A I McClatchey1, I Saotome, K Mercer
1Department of Biology and the Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. mcclatch@helix.mgh.harvard.edu
Abstract:
A role for the membrane/cytoskeleton interface in the development and progression of cancer is established, yet poorly understood. The neurofibromatosis type II (NF2) tumor suppressor gene encodes a member of the ezrin/radixin/moesin (ERM) family of membrane/cytoskeleton linker proteins thought to be important for cell adhesion and motility. We report that in contrast to the narrow spectrum of benign tumors in human NF2 patients, Nf2 heterozygous mice develop a variety of malignant tumors. Using the fact that Nf2 is linked to the p53 tumor suppressor locus in the mouse we have also investigated the effects of genetic linkage of cancer-predisposing mutations on tumorigenesis and examined the genetic pathway to tumor formation involving Nf2 loss. Importantly, we observed a very high rate of metastasis associated with Nf2 deficiency, with or without loss of p53 function, and we provide experimental evidence supporting a role for Nf2 loss in metastatic potential. Together, our results suggest an important role for the NF2 tumor suppressor, and perhaps the ERM family in tumor formation and metastasis.
Insights
The neurofibromatosis type II (NF2) tumor suppressor gene loss promotes malignant tumor formation and metastasis in mice. NF2 deficiency drives metastatic potential, independent of p53 function, highlighting its critical role in cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The membrane/cytoskeleton interface is crucial in cancer development, but its mechanisms remain unclear.
- The neurofibromatosis type II (NF2) gene encodes an ezrin/radixin/moesin (ERM) protein involved in cell adhesion and motility.
Purpose of the Study:
- To investigate the role of the NF2 tumor suppressor in tumorigenesis and metastasis.
- To examine the impact of genetic linkage between NF2 and p53 on cancer development.
Main Methods:
- Analysis of tumor development in Nf2 heterozygous mice.
- Investigation of the genetic pathway involving Nf2 loss and its relation to p53.
- Assessment of metastatic potential in Nf2-deficient models.
Main Results:
- Nf2 heterozygous mice developed diverse malignant tumors, unlike benign tumors in human NF2 patients.
- A high rate of metastasis was observed in Nf2-deficient mice, irrespective of p53 status.
- Experimental evidence confirmed Nf2 loss contributes to metastatic potential.
Conclusions:
- NF2 plays a significant role in both tumor formation and metastasis.
- The ERM protein family may also be implicated in cancer progression.
- Understanding NF2's function offers insights into cancer treatment strategies.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
